Skip to main content

Want a detailed portfolio tracker?

BioVie (BIVI) P/E (2014 - 2026)

BioVie (BIVI) P/E from May 5, 2014 to Jun 3, 2026. The TTM BioVie (BIVI) P/E is -0.41. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioVie (BIVI)

YearP/EChange
2026-0.41+70.96%
2025-0.24-90.59%
2024-2.56-71.30%
2023-8.93-88.76%
2022-79.45-79.57%
2021-388.95-74.02%
2020-1.50K+394.86%
2019-302.51+69.14%
2018-178.86-83.73%
2017-1.10K-82.57%
2016-6.31K+83.17%
2015-3.44K-32.49%
2014-5.10KN/A

Comparison BioVie (BIVI) P/E with competitors

BioVie (BIVI) P/E is -0.41.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.41%
NBYStablecoin Development Corp0.10-124.79%
ENLVEnlivex Therapeutics Ltd0.15-136.43%
FGENFibroGen Inc0.24-158.22%
TRAWTraws Pharma Inc0.47-214.68%
FBIOFortress Biotech Inc0.71-271.25%
CHRSCoherus Biosciences Inc0.98-337.25%
ORMPOramed Pharmaceuticals Inc1.47-457.39%
AGENAgenus Inc2.05-596.86%
VIVSVivoSim Labs Inc2.54-715.06%
INVAInnoviva Inc3.19-873.37%
CRMDCorMedix Inc3.65-984.27%
ABEOAbeona Therapeutics Inc4.20-1119.93%
VXRTVaxart Inc4.26-1133.66%
CVACCureVac N.V.4.45-1178.29%
SRPTSarepta Therapeutics Inc4.62-1221.61%
GLPGGalapagos NV4.86-1278.52%
RIGLRigel Pharmaceuticals4.92-1293.24%
ZVRAZevra Therapeutics Inc4.97-1306.46%
ABUSArbutus Biopharma Corp5.69-1481.03%
CGENCompugen Ltd7.38-1891.00%
AUPHAurinia Pharmaceuticals Inc9.25-2343.98%
ACADAcadia Pharmaceuticals Inc9.59-2425.63%
OMEROmeros Corporation9.88-2497.28%
PLXProtalix BioTherapeutics Inc9.91-2503.51%
SPROSpero Therapeutics Inc10.73-2703.77%
ADMAAdma Biologics Inc11.33-2848.31%
SVASinovac Biotech Ltd11.44-2873.87%
TBPHTheravance Biopharma Inc11.78-2956.49%
HRMYHarmony Biosciences Holdings Inc12.18-3054.44%
TGTXTG Therapeutics Inc13.18-3296.75%
INCYIncyte Corp13.38-3345.89%
SABSSAB Biotherapeutics Inc14.06-3509.79%
XOMAXOMA Corp14.95-3725.06%
REGNRegeneron Pharmaceuticals Inc14.98-3733.55%
PBYIPuma Biotechnology Inc15.05-3750.58%
EXELExelixis Inc15.79-3931.14%
NAGENiagen Bioscience Inc16.35-4067.00%
CPRXCatalyst Pharmaceuticals Inc17.34-4307.08%
MDXGMimedx Group Inc17.38-4314.50%
ARGXArgen X SE23.07-5696.16%
HALOHalozyme Therapeutics Inc23.20-5727.45%
XOMAOXOMA Corp25.34-6247.55%
VRTXVertex Pharmaceuticals Inc25.66-6322.98%
XOMAPXOMA Corp25.67-6326.45%
CTMXCytomX Therapeutics Inc25.70-6333.20%
ASNDAscendis Pharma A/S26.35-6492.36%
RPRXRoyalty Pharma plc - Class A27.50-6769.19%
SLNOSoleno Therapeutics Inc29.02-7137.86%
LGNDLigand Pharmaceuticals Inc - Class B30.19-7421.94%
BMRNBiomarin Pharmaceutical Inc37.51-9197.64%
APLSApellis Pharmaceuticals Inc39.02-9564.85%
KRYSKrystal Biotech Inc39.70-9728.92%
GMABGenmab40.20-9851.65%
ONCBeiGene Ltd67.03-16357.85%
TECHBio-Techne Corp68.59-16738.20%
VCELVericel Corp80.63-19657.18%
PHARPharming Group N.V.87.74-21381.99%
ALNYAlnylam Pharmaceuticals Inc124.93-30403.54%
TLXTelix Pharmaceuticals Ltd139.89-34031.46%
CORTCorcept Therapeutics Inc158.39-38518.43%